Linda Sciuto

1.6k total citations
16 papers, 725 citations indexed

About

Linda Sciuto is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Linda Sciuto has authored 16 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Linda Sciuto's work include Lung Cancer Research Studies (5 papers), Cancer therapeutics and mechanisms (4 papers) and Breast Cancer Treatment Studies (4 papers). Linda Sciuto is often cited by papers focused on Lung Cancer Research Studies (5 papers), Cancer therapeutics and mechanisms (4 papers) and Breast Cancer Treatment Studies (4 papers). Linda Sciuto collaborates with scholars based in United States, Canada and Japan. Linda Sciuto's co-authors include Sharon L. Smith, David N. Danforth, Cynthia Ménard, Marc E. Lippman, Matthew M. Poggi, Seth M. Steinberg, Rosemary M. Altemus, Allen S. Lichter, David J. Liewehr and Kevin Camphausen and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer.

In The Last Decade

Linda Sciuto

16 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Linda Sciuto United States	9	445	280	266	245	139	16	725
Adrian Murray Brunt United Kingdom	14	344 0.8×	171 0.6×	372 1.4×	127 0.5×	180 1.3×	50	752
F. Laki France	14	475 1.1×	278 1.0×	216 0.8×	182 0.7×	90 0.6×	40	658
Werner Audretsch Germany	15	582 1.3×	255 0.9×	186 0.7×	457 1.9×	134 1.0×	34	895
Leela Krishnan United States	16	559 1.3×	250 0.9×	302 1.1×	419 1.7×	110 0.8×	42	922
Jean-Rémy Garbay France	11	310 0.7×	140 0.5×	186 0.7×	181 0.7×	120 0.9×	20	604
Boon Chua Australia	21	934 2.1×	555 2.0×	486 1.8×	357 1.5×	172 1.2×	57	1.2k
Maria Carmen De Santis Italy	14	285 0.6×	97 0.3×	212 0.8×	96 0.4×	129 0.9×	63	521
T Lingos United States	5	439 1.0×	198 0.7×	287 1.1×	235 1.0×	210 1.5×	9	756
Carol Rush United States	7	574 1.3×	293 1.0×	255 1.0×	270 1.1×	159 1.1×	10	872
Jarosław Łyczek Poland	7	417 0.9×	203 0.7×	175 0.7×	146 0.6×	97 0.7×	23	583

Countries citing papers authored by Linda Sciuto

Since Specialization

Citations

This map shows the geographic impact of Linda Sciuto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Sciuto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Sciuto more than expected).

Fields of papers citing papers by Linda Sciuto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Sciuto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Sciuto. The network helps show where Linda Sciuto may publish in the future.

Co-authorship network of co-authors of Linda Sciuto

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Sciuto. A scholar is included among the top collaborators of Linda Sciuto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Sciuto. Linda Sciuto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Desai, Parth, Nobuyuki Takahashi, Samantha Nichols, et al.. (2024). Tazemetostat in combination with topotecan and pembrolizumab in patients with recurrent small cell lung cancer.. Journal of Clinical Oncology. 42(16_suppl). TPS8130–TPS8130. 5 indexed citations

Abel, Melissa L., Parth Desai, Christophe E. Redon, et al.. (2023). Abstract CT268: Targeting replication stress and chemotherapy resistance with a combination of sacituzumab govitecan and berzosertib: A phase I clinical trial. Cancer Research. 83(8_Supplement). CT268–CT268. 3 indexed citations

Thomas, Anish, Shaun D. Fontaine, Morgan E. Diolaiti, et al.. (2022). PLX038: A Long-Acting Topoisomerase I Inhibitor With Robust Antitumor Activity in ATM -Deficient Tumors and Potent Synergy With PARP Inhibitors. Molecular Cancer Therapeutics. 21(11). 1722–1728. 7 indexed citations

Lissa, Delphine, Nobuyuki Takahashi, Parth Desai, et al.. (2022). Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models. Nature Communications. 13(1). 2023–2023. 60 indexed citations

Takahashi, Nobuyuki, Parth Desai, Linda Sciuto, et al.. (2022). Targeting genomic instability in extrapulmonary small cell neuroendocrine cancers: A phase II study with ATR inhibitor berzosertib and topotecan.. Journal of Clinical Oncology. 40(16_suppl). 8518–8518. 2 indexed citations

Schmidt, Keith T., Alwin D. R. Huitema, Thomas P. C. Dorlo, et al.. (2020). Population pharmacokinetic analysis of nanoparticle-bound and free camptothecin after administration of NLG207 in adults with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 86(4). 475–486. 12 indexed citations

Rajan, Arun, Chul Kim, Udayan Guha, et al.. (2017). OA18.02 Evaluation of a Modified Dosing Regimen (2-Weeks on/1-Week off) of Sunitinib as Part of a Phase II Trial in Thymic Carcinoma. Journal of Thoracic Oncology. 12(1). S313–S314. 6 indexed citations

Simone, Nicole L., Tu Dan, Sharon L. Smith, et al.. (2011). Twenty-five year results of the national cancer institute randomized breast conservation trial. Breast Cancer Research and Treatment. 132(1). 197–203. 57 indexed citations

Citrin, Deborah E., Anna Likhacheva, Linda Sciuto, et al.. (2008). Long-Term Outcomes and Toxicity of Concurrent Paclitaxel and Radiotherapy for Locally Advanced Head-and-Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 74(4). 1040–1046. 38 indexed citations

10.

Simone, Nicole L., Cynthia Ménard, Benjamin P. Soule, et al.. (2007). Intrarectal Amifostine During External Beam Radiation Therapy for Prostate Cancer Produces Significant Improvements in Quality of Life Measured by EPIC Score. International Journal of Radiation Oncology*Biology*Physics. 70(1). 90–95. 41 indexed citations

11.

Singh, Anurag K., Cynthia Ménard, Peter Guion, et al.. (2006). Intrarectal amifostine suspension may protect against acute proctitis during radiation therapy for prostate cancer: A pilot study. International Journal of Radiation Oncology*Biology*Physics. 65(4). 1008–1013. 24 indexed citations

12.

Danforth, David N., Paul S. Albert, Linda Sciuto, et al.. (2005). Early ipsilateral breast tumor recurrences after breast conservation affect survival: An analysis of the National Cancer Institute randomized trial. International Journal of Radiation Oncology*Biology*Physics. 62(3). 785–789. 18 indexed citations

13.

Muanza, Thierry, Paul S. Albert, Sharon L. Smith, et al.. (2005). Comparing measures of acute bowel toxicity in patients with prostate cancer treated with external beam radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 62(5). 1316–1321. 21 indexed citations

14.

Poggi, Matthew M., David N. Danforth, Linda Sciuto, et al.. (2003). Eighteen‐year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy. Cancer. 98(4). 697–702. 429 indexed citations

15.

Poggi, Matthew M., David N. Danforth, Linda Sciuto, et al.. (2002). Eighteen-year results in the treatment of early-stage breast cancer with breast conservation versus mastectomy. International Journal of Radiation Oncology*Biology*Physics. 54(2). 55–56. 1 indexed citations

16.

Caruso, Giuseppe, et al.. (1990). Respiratory function and liver cirrhosis.. PubMed. 12(2). 83–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact